Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Caesarean and Corticotherapy
This study is currently recruiting participants.
Verified by University Hospital, Strasbourg, France, January 2008
Sponsored by: University Hospital, Strasbourg, France
Information provided by: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT00446953
  Purpose

Comparison of two randomized group :

  • caesarean section planned at 38 weeks after 2 antenatal injections of 12 mg of betamethasone 48 h before.
  • caesarean section planned at 39 weeks without corticosteroid.

The aim is to demonstrate that programming caesarean section at 38 weeks of pregnancy, after antenatal corticosteroid, allows to avoid caesarean section in emergency (because of a labour before 39 weeks), without increasing the neonatal respiratory distress rate.


Condition Intervention Phase
Neonatal Distress
Drug: betamethasone
Other: placebo
Phase IV

MedlinePlus related topics: Cesarean Section
Drug Information available for: Corticosteroids Betamethasone Bentelan Betamethasone dipropionate
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study
Official Title: Interest in Programming Caesarean Section at 38 Weeks of Pregnancy With Antenatal Betamethasone to Prevent Neonatal Respiratory Distress and to Avoid Emergency Caesarean Section Before Planned Date.

Further study details as provided by University Hospital, Strasbourg, France:

Primary Outcome Measures:
  • Neonatal respiratory distress [ Time Frame: 15 days ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 600
Study Start Date: March 2007
Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
2x 12 mg betamethazone
Drug: betamethasone
2x12 mg betamethazone c-section at 38 weeks
2: Placebo Comparator
no drugs
Other: placebo
c-section at 39 weeks

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • woman who needs elective caesarean section

Exclusion Criteria:

  • multiple pregnancy
  • toxaemia
  • rhesus immunization
  • fetal infection
  • maternal gastro-duodenal ulcer
  • mother HIV+
  • prior injection of corticosteroid during the pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00446953

Contacts
Contact: Bruno Langer, MD 0333 88127503 bruno.langer@chru-strasbourg.fr
Contact: Nicolas Sananès, Resident nsananes@hotmail.com

Locations
France
Hôpital de Hautepierre Recruiting
Strasbourg, France, 67000
Contact: Bruno Langer, MD     33388127503     bruno.langer@chru-strasbourg.fr    
Sub-Investigator: Jean-Jacques Baldauf, MD            
Sub-Investigator: Françoise Brand, MD            
Sub-Investigator: Eric Boudier, MD            
Sub-Investigator: Eric David, MD            
Sub-Investigator: Gabrielle Fritz, MD            
Sub-Investigator: Christine Helmlinger, MD            
Sub-Investigator: Brigitte Viville, MD            
Sub-Investigator: Emmanuelle Baulon, MD            
Principal Investigator: Bruno Langer, MD            
Sub-Investigator: Benoît Escande, MD            
Sub-Investigator: Pierre Kuhn, MD            
CMCO-SIHCUS Recruiting
Schiltigheim, France, 67303
Contact: Germain Aissi, MD     333 88628349     germain.aissi@sihcus.fr    
Sub-Investigator: Michèle Weil, MD            
Sub-Investigator: Romain Favre, MD            
Sub-Investigator: Catherine Rongières, MD            
Sub-Investigator: Jeanine Ohl, MD            
Sub-Investigator: Karima Bettahar, MD            
Sub-Investigator: Monique Kohler, MD            
Principal Investigator: Germain Aissi, MD            
Sub-Investigator: Olivier Garbin, MD            
Sub-Investigator: Véronique Thoma, MD            
Sub-Investigator: Olivier Pirello, MD            
Le Parc Centre pour la Mère et l'Enfant Recruiting
Colmar, France, 68000
Contact: Richard Kutnahorsky, MD     33389126092     kutnahorsky@mac.com    
Principal Investigator: Richard Kutnahorsky, MD            
Sub-Investigator: Didier Chognot, MD            
Sub-Investigator: Jean-Luc Gollner, MD            
Sub-Investigator: Laurent Beinert, MD            
Sub-Investigator: Stéphane Lucas, MD            
Sub-Investigator: Martine Macchi-Gerrer, MD            
Sub-Investigator: Jean-Marc Renglewicz, MD            
Sub-Investigator: Jean-Yves Egloff, MD            
Sub-Investigator: Michel Schiltz, MD            
Sub-Investigator: Elie Haidar, MD            
Hôpital de Hasenrain Recruiting
Mulhouse, France, 68051
Contact: Philippe Weber, MD     033389646977     weberph@ch-mulhouse.fr    
Sub-Investigator: Laurence Keller, MD            
Principal Investigator: Philippe Weber, MD            
Sub-Investigator: Jean Nakhleh, MD            
Sub-Investigator: Zafer Kara, MD            
Sub-Investigator: Charles Gilliot, MD            
Sub-Investigator: Edgar Montoya, MD            
Sub-Investigator: Francine Achatz, MD            
Sub-Investigator: Anne Fleury, MD            
Sub-Investigator: Francisco Delpiano, MD            
Sub-Investigator: Didier Cohen, MD            
Sub-Investigator: Bernard Ott, MD            
Centre Hospitalier de Haguenau Recruiting
Haguenau, France, 67504
Contact: Vincent Zerr, MD     00333.88.06.30.44     vincent.zerr@ch-haguenau.fr    
Principal Investigator: Vincent Zerr, MD            
Sub-Investigator: Abdou Chami, MD            
Sub-Investigator: Michel Foegle, MD            
Sub-Investigator: Etienne Keller, MD            
Sub-Investigator: Ahmad Bakri, MD            
Sub-Investigator: Michèle Lehmann, MD            
Sub-Investigator: Karim Dadoun, MD            
Sub-Investigator: Chantal Bolender, MD            
Sub-Investigator: Marie-Pierre Streicher, MD            
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Principal Investigator: Bruno Langer, MD Les Hôpitaux Universitaires de Strasbourg
  More Information

Responsible Party: University Hospital, Strasbourg, France ( Emmanuel Lavoué, Directeur Adjoint de la Recherche Clinique et de l'Innovation )
Study ID Numbers: 3740
Study First Received: March 12, 2007
Last Updated: January 23, 2008
ClinicalTrials.gov Identifier: NCT00446953  
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Strasbourg, France:
Caesarean section
Corticosteroids
Betamethasone
Neonatal respiratory distress

Study placed in the following topic categories:
Betamethasone-17,21-dipropionate
Sodium phosphate
Betamethasone sodium phosphate
Emergencies
Betamethasone

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Respiratory System Agents
Therapeutic Uses
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Anti-Asthmatic Agents
Hormones
Glucocorticoids
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009